USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
DISCOVERYBIOMED, INC.
Address:
400 Riverhills Business Park
BIRMINGHAM, AL 35242-8101
Phone:
(205) 918-8138
URL:
EIN:
126018855
DUNS:
807018333
Number of Employees:
5
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $661,260.00 2

Award List:

Inhibitors of IgH Gene Enhancers for the Treatment of Multiple Myeloma

Award Year / Program / Phase:
2013 / SBIR / Phase I
Award Amount:
$224,700.00
Agency:
HHS
Principal Investigator:
Eric C. Seales – 205-307-6535
Abstract:
DESCRIPTION (provided by applicant): DiscoveryBioMed, Inc. (DBM) has launched an innovative and automation-friendly drug discovery program to screen synthetic organic small molecule collections on differentiated human adipocyte platforms to discover a newclass of therapeutic drugs for type 2… More

DBM Anti-Proliferative Lead Small Molecules for Polycystic Kidney Disease

Award Year / Program / Phase:
2013 / SBIR / Phase I
Award Amount:
$436,560.00
Agency:
HHS
Principal Investigator:
Erik M. Schwiebert – 205-918-8138
Abstract:
DESCRIPTION (provided by applicant): An important discovery and validation event occurred recently within human cell-based drug discovery programs at DiscoveryBioMed, Inc. (DBM), yielding a lead class of cytostatic anti-proliferative small molecules thatdisplay nanomolar potency and marked efficacy… More